Why You Can Still Be Exhausted on CPAP Even When Your AHI Looks Perfect
What being still tired on CPAP actually points to when your machine says the apnoea is controlled
Your machine says the apnoea is controlled and your body disagrees, so here is the European workup that finds the real cause.
Why You Are Still Tired on CPAP When Your AHI Looks Perfect
Being still tired on CPAP while your residual apnoea-hypopnoea index sits under five is a recognised clinical situation, not a personal failure. Your machine reports how well it splinted your airway. It cannot report how long you slept, how broken that sleep was, or what else drains your daytime energy.
The residual AHI, written IAH on French reports, measures one thing in one organ system. If you are unsure what your AHI number really represents, settle that first. Everything below is the differential a European sleep physician works through once that number is already normal.
In the European Sleep Apnoea Database (ESADA) analysis of 4,853 CPAP-treated patients across more than 30 European centres, published in Frontiers in Neurology in 2021, excessive daytime sleepiness fell from 56% before treatment to 28.2% at first follow-up. A 2025 meta-analysis in ERJ Open Research, covering seven studies and 2,245 patients, put the persisting figure at 7-30%.
A French multicentre study of 502 CPAP-compliant patients across 37 sleep centres found the same problem in 12.0% of them (Pepin et al., European Respiratory Journal, 2009). The clinical name for it is residual excessive daytime sleepiness, shortened to RES.
- A normal residual AHI proves the airway stayed open. It does not prove your sleep was restorative.
- The next step is a structured workup, not a guess at a higher pressure.
The Six-Month Rule That Decides Whether This Is Even a Problem
Residual sleepiness should only be assessed as a diagnosis after six months of treatment. The European Respiratory Review consensus published in 2022 as the European view sets that threshold because sleepiness resolves spontaneously in about half of sleepy patients.
The ESADA timeline shows why the calendar matters so much. Residual sleepiness peaked at 40% during the first three months of CPAP, then fell to 13-19% between four months and two years (Bonsignore et al., ESADA, 2021). Week six is early. Month eight is a real data point.
| Time on CPAP | What is normal | What it means for you |
|---|---|---|
| Weeks 1-4 | Broken nights, mask fiddling, swallowed air, unusually vivid dreams | Adaptation. REM rebound and slow-wave sleep rebound are expected |
| Months 1-3 | Up to 40% of patients still sleepy (ESADA, 2021) | Too early to label this residual sleepiness |
| Months 4-24 | 13-19% still sleepy (ESADA, 2021) | Persisting sleepiness now deserves investigation |
| After 6 months | European Respiratory Review 2022 assessment threshold | A formal workup for residual sleepiness is appropriate |
- Half of sleepy patients improve without any extra intervention (European Respiratory Review, 2022).
- Before six months, patience is a legitimate medical plan.
- After six months, persistent sleepiness is a diagnosis to chase, not a mood to tolerate.
Fatigue and Sleepiness Are Not the Same Complaint
Sleepiness is the drive to fall asleep. Fatigue is a lack of energy without that drive. Physicians treat them as separate tracks, and the sorting tool is the Epworth Sleepiness Scale, a short questionnaire scoring your chance of dozing.
An Epworth Sleepiness Scale score of 11 or more is positive for excessive sleepiness. A score of 16 or more indicates severe sleepiness. Score yourself honestly before your appointment, because that number decides what comes next.
| Feature | True sleepiness | Fatigue without sleepiness |
|---|---|---|
| How you describe it | I fight to stay awake at red lights | I am wiped out but could not nap |
| Typical Epworth score | 11 or above, often 16 or above | Usually below 11 |
| Common drivers | Sleep debt, periodic limb movements, under-treated apnoea, central hypersomnia | Thyroid disease, iron deficiency, low mood, medication effects |
| First investigations | Actigraphy, machine data review, possibly an MSLT | Blood panel and depression screen |
- Bring a scored Epworth to the appointment. It changes the consultation immediately.
- Fatigue points at blood work. Sleepiness points at sleep measurement.
What Your Machine Genuinely Cannot Measure
CPAP software counts breathing events. It does not stage sleep, count arousals or measure oxygen. Four blind spots explain most cases where the screen looks flawless and the person feels wrecked.
1Arousals your machine never scored
A respiratory effort-related arousal, or RERA, wakes the brain without meeting the criteria for an apnoea or a hypopnoea. Flow limitation and upper airway resistance syndrome, abbreviated UARS, work the same way. The arousal index, not the AHI, is the measure that tracks sleep fragmentation and how refreshed you feel.
2Leak that fragments the second half of the night
Ask for the 95th percentile leak, not the average. Mouth leak and large leak cluster in REM sleep, when muscle tone is lowest, so the damage lands on exactly the sleep stage you need most. Nasal congestion is a frequent hidden driver.
3Oxygen the machine never saw
CPAP machines do not measure blood oxygen. An oxygen desaturation index, or ODI, recorded by overnight pulse oximetry can reveal dips your device scored as nothing at all, which is one reason it helps to know how an ODI and SpO2 report is read.
4Pressure that keeps moving
APAP algorithms hunt for pressure through the night. For some people a fixed-pressure setting is steadier and less disruptive. This is a titration question for your clinician, never a dial to turn yourself.
- A residual AHI under five can sit alongside heavy sleep fragmentation.
- Ask for 95th percentile leak, residual central index and usage distribution.
The Conditions CPAP Was Never Going to Fix
Residual sleepiness often has a second cause sitting behind the apnoea. In the French multicentre study, prevalence fell from 12.0% to 6.0% once patients with confounding conditions were excluded (Pepin et al., European Respiratory Journal, 2009). Roughly half had something else going on.
Comorbid insomnia and sleep apnoea
Insomnia symptoms are present in 40-60% of people with obstructive sleep apnoea, a combination known as COMISA, and it is associated with reduced adherence to positive airway pressure and clearly worse daytime functioning (International Journal of Environmental Research and Public Health, 2021). The treatment is cognitive behavioural therapy for insomnia, or CBT-I, not another pressure adjustment.
Sleep debt and body-clock problems
Insufficient sleep syndrome is the simplest explanation and an easily missed one. Seven hours in bed minus mask fiddling is not seven hours of sleep. Shift work and circadian rhythm sleep-wake disorders look identical, which is why actigraphy sits in the first-line workup.
Restless legs and limb movements
Restless legs syndrome, also called Willis-Ekbom disease, matters because periodic limb movements of sleep, or PLMS, break sleep continuity without waking you fully. A high PLM index, or a bed partner describing kicking, justifies iron testing.
Thyroid, mood and central hypersomnia
Hypothyroidism is checked with TSH and, if abnormal, free T4. Depressive symptoms were among the factors significantly associated with residual sleepiness in the 2025 ERJ Open Research meta-analysis, alongside female sex and poorer adherence. If everything returns normal and sleepiness is severe, narcolepsy type 2 and idiopathic hypersomnia enter the frame.
- COMISA is the single most common reason a compliant CPAP user still feels wrecked.
- Cognitive behavioural therapy treats it. More pressure does not.
The Blood Panel a European Clinic Orders When You Are Still Tired on CPAP
The European first-line workup is short and specific. The European Respiratory Review 2022 pathway names full blood count, TSH, urea and electrolytes, a depression screen and actigraphy, with full polysomnography reserved for suspected central hypersomnia.
| Test | What it looks for | The number that matters |
|---|---|---|
| Full blood count | Anaemia as a fatigue driver | Your laboratory reference range |
| TSH, then free T4 if abnormal | Hypothyroidism | Local assay range |
| Urea and electrolytes | Renal and metabolic contributors | Standard reference ranges |
| Serum ferritin | Iron deficiency driving restless legs | Iron treatment indicated at 75 ng/mL or below (AASM, 2025) |
| Transferrin saturation | Iron deficiency without anaemia | Below 20% (AASM, 2025) |
| Depression screening | Mood as a fatigue driver | A validated questionnaire such as the PHQ-9 |
| Actigraphy | Real sleep duration and timing | Worn for 1-2 weeks before the review |
The American Academy of Sleep Medicine guideline published in 2025 recommends ferritin and transferrin saturation testing for everyone with clinically significant restless legs, with intravenous iron reserved for ferritin between 75 and 100 ng/mL. A normal full blood count does not rule iron deficiency out, which is why ferritin belongs on the form.
- Request the five first-line items explicitly, plus ferritin and transferrin saturation.
- Ferritin at or below 75 ng/mL is an actionable threshold, not a borderline curiosity.
MSLT and MWT, the Two Tests Nobody Explains
The Multiple Sleep Latency Test measures how fast you fall asleep across a series of daytime nap opportunities, run the day after a full overnight polysomnography. It is the test used to identify narcolepsy type 2 and idiopathic hypersomnia once everything else is normal.
The Maintenance of Wakefulness Test measures the opposite ability, which is how long you can stay awake sitting still in a dim room. In Europe it is the test that informs fitness-to-drive decisions, so professional drivers encounter it more often than anyone else.
Sleep centres are cautious about ordering either, because both need a monitored night plus a full day of testing. That also explains a European blind spot. Respiratory polygraphy, the routine first-line study in much of Europe, records breathing but scores neither arousals nor sleep stages, so a normal polygraphie ventilatoire cannot answer this question.
- MSLT asks how fast you fall asleep. MWT asks how long you stay awake.
- A normal respiratory polygraphy cannot exclude an arousal or hypersomnia problem.
What Actually Happens at the Re-Titration Appointment
A re-titration review is a data reading, not a pressure guess. Your clinician downloads the device data from the memory card or the telemonitoring platform, then reads several numbers rather than the single one you see.
1Usage, honestly
Not the average, but how many nights reached four hours and whether the mask comes off before dawn.
2Residual AHI broken down
Obstructive versus central events. A rising residual central index changes the therapy conversation completely.
3Leak at the 95th percentile
Plus when it spikes. Persistent mouth leak triggers a mask, humidification or nasal obstruction review.
4Pressure at the 95th percentile
This shows whether an auto-adjusting device chases pressure all night or has settled at a stable level.
They can adjust pressure, change the mask, add humidification, order bloods and start actigraphy the same day. A new sleep study, an MSLT or an MWT needs separate scheduling, so raise it now.
- Ask for the printed download, not a verbal summary.
- Request the blood panel at this visit so results exist before your follow-up.
Driving Rules in Europe If the Sleepiness Persists
Driving with treated sleep apnoea is governed across the EU by Commission Directive 2014/85/EU, not by local licensing habit. It defines moderate obstructive sleep apnoea syndrome as an AHI of 15 to 29 with excessive daytime sleepiness, and severe as an AHI of 30 or above with sleepiness.
Licence holders must show adequate control of their condition, compliance with treatment and improvement of sleepiness, confirmed by authorised medical opinion. Periodic review is required at intervals not exceeding three years for Group 1 drivers and one year for Group 2 professional drivers, so it pays to know how sleep apnoea and your driving licence interact.
NHS guidance in the United Kingdom is blunt. If sleep apnoea with excessive sleepiness has been confirmed, you must not drive until symptoms are under control, with notification rules published on GOV.UK.
- Group 1 drivers face review at least every three years, Group 2 every year.
- Control of sleepiness, not adherence hours alone, is the licensing standard.
Medicines Licensed in Europe for People Still Tired on CPAP
Europe has authorised wakefulness medicines for this exact situation, which almost no article mentions. Pitolisant, marketed as Ozawade, received EU marketing authorisation on 1 September 2021 to improve wakefulness and reduce excessive daytime sleepiness in adults with obstructive sleep apnoea where CPAP has not adequately improved sleepiness or cannot be tolerated (European Medicines Agency, 2021).
Solriamfetol, marketed as Sunosi, received EU marketing authorisation on 16 January 2020, for adults with obstructive sleep apnoea whose sleepiness has not been satisfactorily treated by primary therapy such as CPAP (European Medicines Agency, 2020).
The gap before those approvals matters. The EMA withdrew the modafinil sleep apnoea indication in 2011 on risk-benefit grounds, leaving Europe with no authorised option for nine years. Neither medicine replaces finding the cause.
- Two medicines are EU-authorised specifically for residual sleepiness in sleep apnoea.
- They are prescribed after the workup, never instead of it.
When the Finding Is That CPAP Is Not the Right Therapy for You
Sometimes the honest conclusion is intolerance rather than under-treatment. Adherence is counted as at least four hours per night, and in France reimbursement is tied directly to telemonitored use, known as télésuivi, with roughly 112 hours across a four-week period supporting the full forfait and an adaptation tolerance during the first 13 weeks.
That system creates a real incentive to overstate usage. Tell your physician the truth anyway, because a false adherence figure guarantees the wrong diagnosis. A French CPAP or mandibular advancement device prescription also needs an accord préalable from the Assurance Maladie via amelipro, mandatory since 31 December 2024.
If the review concludes the underlying apnoea is mild to moderate and the real barrier is tolerance, ask your specialist to weigh the alternatives with you. Those include a mandibular advancement device, positional therapy, an ENT assessment of nasal obstruction, or a CE-certified soft silicone intranasal stent such as Back2Sleep, which holds the nasal airway open during sleep with no electricity, noise or tubing.
- Poor tolerance is a treatable problem, not a character flaw.
- Alternatives suit mild-to-moderate apnoea and belong in a specialist conversation.
What Back2Sleep Users Say
Frequently Asked Questions
Why am I still tired on CPAP when my AHI is under 5?
A residual AHI under 5 only proves the airway stayed open. It says nothing about arousals, mask leak, how long you actually slept, or other conditions. In the European ESADA cohort published in 2021, 28.2% of treated patients were still sleepy at first follow-up. Ask about arousals, leak and blood tests.
How long does it take to feel better after starting CPAP?
Improvement often begins within weeks, but the full timeline is longer than most people expect. Residual sleepiness peaked at 40% during the first three months, then fell to 13-19% between four months and two years (ESADA, 2021). The European Respiratory Review 2022 pathway says formal assessment should only start after six months.
What blood tests should I ask for if I'm still sleepy on CPAP?
The European Respiratory Review 2022 first-line panel is full blood count, TSH, urea and electrolytes, plus a depression screen and actigraphy. If you have restless legs, add serum ferritin and transferrin saturation. The AASM 2025 guideline indicates iron treatment at ferritin of 75 ng/mL or below, or saturation under 20%.
What is a normal Epworth score when you're on CPAP?
Below 11 is considered normal. A score of 11 or more is positive for excessive sleepiness, and 16 or more indicates severe sleepiness. Score yourself before the appointment. A high score points toward sleep measurement and actigraphy, while a low score with exhaustion points toward blood tests and mood screening instead.
Is my mask leak making me tired even though my AHI looks fine?
It can be. Averaged leak hides the problem, so ask for the 95th percentile figure instead. Mouth leak and large leak cluster during REM sleep, when muscle tone drops, fragmenting the stage you need most. Nasal congestion is a common driver, so a mask, humidification or ENT review helps.
Can a home sleep test show why I'm still tired on CPAP?
Only partly. Respiratory polygraphy, the routine European first-line study, records breathing but scores neither arousals nor sleep stages, so it cannot explain arousal-driven sleepiness. Full polysomnography, sometimes followed the next day by a Multiple Sleep Latency Test, is needed when narcolepsy type 2 or idiopathic hypersomnia is suspected.
Do I have to tell the licensing authority if I'm still sleepy on CPAP?
Rules vary by country, but the direction is consistent. EU Commission Directive 2014/85/EU requires adequate control of the condition and improvement of sleepiness, confirmed by authorised medical opinion, with review at intervals not exceeding three years for Group 1 drivers and one year for Group 2. UK NHS guidance says you must not drive until symptoms are controlled.
Why do I feel worse after starting CPAP?
Early weeks often bring aerophagia, a dry mouth and unusually vivid dreams as suppressed REM sleep rebounds. Treatment-emergent central sleep apnoea can also appear and frequently settles by itself. None of this means the therapy has failed. Report the symptoms so your mask, humidification or pressure mode can be adjusted.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.